EDUCATION, AWARENESS, SUPPORT & ORGAN DONATION
Hepatitis C News
- An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
READ NEWS - FDA Approves Pegasys & Copegus for Children between 5 years & 17 years
READ NEWS - Racial Differences in Eligibility for Hepatitis C Treatment
READ NEWS - HCV Protease Inhibitor Danoprevir Promising in Early Trial
READ NEWS - DDW: Study Backs HCV Screens for All Boomers
READ NEWS - Telemedicine Puts HCV Care in Hands of PCPs
READ NEWS - Telaprevir (Incivek) Approved
READ NEWS - BOCEPREVIR APPROVED
READ NEWS - 4-Drug Combo with Telaprevir and VX-222 Clears HCV at 12 Weeks
READ NEWS - First Sustained Response Data for Polymerase Inhibitor Mericitabine EASL
READ NEWS - Pegylated Interferon Lambda Boosts Response with Few Side Effects EASL
READ NEWS - Boceprevir Helps Hepatitis C Patients with Cirrhosis EASL
READ NEWS - Statin Boosts Response to Pegylated Interferon/Ribavirin EASL
READ NEWS
Important Notice
As the new drugs are used to treat HCV, there will be new challenges to communications between patients and their health care providers. You can help. Please take this anonymous survey that will provide information to help health care professionals address their patients' concerns and ultimately lead to improved patient care.
To view the survey, please click on this link: http://www.sceptercme.com/hepcsurvey
Upcoming Events
- EASL
Berlin, Germany
March 30 – April 3, 2011
http://www.easl.eu/ - DDW
Chicago, IL
May 7 – May 10, 2011
http://www.ddw.org/wmspage.cfm?parm1=679 - 1st World Congress on Controversies in the Management of Viral Hepatitis
(C-Hep)
Barcelona, Spain
May 19 - 22, 2011
www.comtecmed.com/chep - HCV 2011 Symposium
Seattle, WA
Sept. 8 – 11, 2011
http://www.hcv2011.org/ - AASLD
San Francisco, CA
Nov. 4 – 8, 2011
http://www.aasld.org/lm/Pages/default.aspx
This site complies with the HONcode standard for trustworthy health information:
verify here.
The information provided on this site is intended to support, not replace, the relationship that exists between a patient and his/her physician. Hepatitis C Association does not display commercial content or receive funding from advertising products or services.
Support line 908-769-8479
